UNSPSC 51282903: Amifloxacin

This classification denotes a quinolone antibiotic with the molecular formula C16H19FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5TU5227KYQ, chemically known as 6-fluoro-1,4-dihydro-1-(methylamino)-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid but generally known as amifloxacin, which bears US NIH Compound Identifier 55492. Amifloxacin most often comes in mesylate and n-oxide forms.

UNSPSC 51282903 Amifloxacin is a Commodity code for a specific fluoroquinolone antibiotic pharmaceutical product. State and local governments solicit under this code primarily for pharmaceutical warehouse supply contracts and emergency health procurement. The issuing bodies include state health departments and county government purchasing offices, typically acquiring amifloxacin and related antimicrobial agents through cooperative purchasing consortia (such as MMCAP Infuse) or direct competitive procurement for public health stockpiles and community health initiatives. Solicitations are structured as piggyback arrangements on established pharmaceutical supplier contracts or as standalone invitation-for-bid processes with fixed-fee pricing, quarterly delivery schedules, and multi-year initial terms with renewal options.

Recent activity in the code shows a narrow geographic footprint. Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 (solicitation 26482DPHPREPDB53392, completed IFB with a Sep 11, 2026 response date) for related fluoroquinolone products including Ciprofloxacin Hydrochloride 500mg tablets, supplying a 12-month initial term with two one-year renewal options. Seminole County, Florida posted an IFB in June 2026 (IFB60459723LAS, due Jul 26, 2023) for naloxone and drug deactivation systems procurement with quarterly deliveries to the county community health building, though this opportunity does not directly target amifloxacin. The code shows limited recent documented state and local activity specifically for amifloxacin itself; most procurement under related pharmaceutical codes appears concentrated in Illinois and Florida public health and emergency services contexts.